Elevated tryptophan levels in post-withdrawal alcoholics

Acta Psychiatrica Scandinavica

Volumn 94, Issue 6, 1996, Pages 465-470

  Farren, C K ^a   Dinan, T G ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST PATRICK S HOSPITAL   (Ireland)

Author keywords

alcoholism; serotonin; tryptophan

Indexed keywords

HYDROCORTISONE; SEROTONIN; TRYPTOPHAN;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0030464088     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb09892.x     Document Type: Article

References (28)

1. FARREN CK. Serotonin and alcoholism: clinical and experimental research. J Serotonin Res 1995: 1: 9-26.
2. LEMARQUAND D, PIHL RO, BENKELFAT C. Serotonin and alcohol intake, abuse and dependence: clinical evidence. Biol Psychiatry 1994: 36: 326-337.
3. LEMAROUAND D, PIHL RO, BENKELFAT C. Serotonin and alcohol intake, abuse and dependence: findings of animal studies. Biol Psychiatry 1994: 36: 395-421.
4. BADAWY AA-B, EVANS M. The effects of ethanol on tryptophan pyrrolase activity and their comparison with those of phenobarbitone and morphine. Adv Exp Biol Med 1975: 59: 229-251.
5. BADAWY AA-B, PUNJANI NF, EVANS M. Enhancement of rat brain tryptophan metabolism by chronic ethanol administration and possible involvement of decreased liver tryptophan pyrrolase activity. Biochem J 1979: 178: 575-580.
6. LITMAN DA, CORREIA MA. Elevated brain tryptophan and enhanced 5-hydroxytryptamine turnover in acute hepatic heme deficiency: clinical implications. J Pharmacol Exp Ther 1985: 232: 337-345.
7. AMIT Z, BROWN Z, SUTHERLAND A, ROCKMAN G, GILL K, SELVAGGI N. Reduction in alcohol intake in humans as a function of treatment with zimeldine: implications for treatment. In: NARANJO CA, SELLERS EM, ed. Research advances in new psychopharmacological treatments for alcoholism. Amsterdam: Elsevier, 1985.
8. NARANJO CA, SELLERS EM, SULLIVAN JT, WOODLEY DV, KADLEC K, SYKORA K. The serotonin uptake inhibitor citralopram attenuates ethanol intake. Clin Pharmacol Ther 1987: 41: 266-274.
9. NARANJO CA, SULLIVAN JT, KADLEC K, WOODLEY-REMUS DV, KENNEDY G, SELLERS EM. Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 1989: 46: 301-309.
10. KRANZLER HR, DEL BOCA F, KORNER P, BROWN J. Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism. J Subs Abuse Treat 1993: 10: 283-287.
11. KRANZLER HR, BURLESON JA, KORNER P et al. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 1995: 152: 391-397.
12. STOCKWELL T, MURPHY D, HODGSON R. The severity of alcohol dependence questionnaire (SADQ): its use, reliability and validity. Br J Addict 1983: 78: 145-155.
13. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960: 23: 56-62.
14. VON KNORRING L, PALM U, ANDERSSON HE. Relationship between treatment outcome and subtype of alcoholism in men. J Stud Alcohol 1985: 49: 85-92.
15. FARREN C, DINAN TG. Alcoholism and typology: findings in an Irish private hospital population. J Stud Alcohol 1996: 57: 249-252.
16. BANKI CM. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neur Transm 1981: 50: 89-101.
17. AKHTER MI, CLARKE PMS, KRICKA LJ, NICHOLSON G. Urinary metabolites of tryptophan, serotonin and norepinephrine in alcoholics. J Stud Alcohol 1978: 39: 833-841.
18. FRIEDMAN MJ, KRSTULOVIC AM, SEVERINGHAUS JM, BROWN S. Altered conversion of tryptophan to kynurenine in newly abstinent alcoholics. Biol Psychiatry 1988: 23: 89-93.
19. COMINGS DE, MUHLEMAN D, DIETZ GW JR, DONLON T. Human tryptophan oxygenase localized to 4q31: possible implications for alcoholism and other behavioral disorders. Genomics 1991: 9: 301-308.
20. BUYDENS-BRANCHEY L, BRANCHEY M, WORNER TM, ZUCKER D, ARAMSOMBATDEE E, LIEBER CS. Increase in tryptophan oxygenase activity in alcoholic patients. Alcohol Clin Exp Res 1988: 12: 163-167.
21. BECK O, BORG S, SEDVALL G. Tryptophan levels in human cerebrospinal fluid after acute and chronic ethanol consumption. Drug Alcohol Depend 1983: 12: 217-222.
22. BUYDENS-BRANCHEY L, BRANCHEY M, NOUMAIR D, LIEBER CS. Age of alcoholism onset. II. Relationship to susceptibility to serotonin precursor availability. Arch Gen Psychiatry 1989: 46: 231-236.
23. BANKI CM. Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neur Transm 1981: 50: 232-238.
24. BRANCHEY L, SHAW S, LIEBER CS. Ethanol impairs tryptophan transport into the brain and depresses serotonin. Life Sci 1981: 29: 2751-2755.
25. BRANCHEY L, BRANCHEY M, SHAW S, LIEBER CS. Relationship between changes in plasma amino acids and depression in alcoholic patients. Am J Psychiatry 1984: 141: 1212-1215.
26. BADAWY AA, MORGAN CJ. THOMAS R. Tryptophan and 5-hydroxytryptamine metabolism in alcoholism. Alcohol Alcoholism 1993: 28 (Suppl. 2): 231-235.
27. BRANCHEY L, BRANCHEY M, SHAW S, LIEBER CS. Depression, suicide and aggression in alcoholics and their relationship to plasma amino acids. Psychiatry Res 1984, 12: 219-226.
28. VIRKKUNNEN M, LINNOILA M. Brain serotonin, type 2 alcoholism and impulsive violence. J Stud Alcohol 1993: Suppl. 11: 163-169.